Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...

A substantial minority of patients diagnosed with fibromyalgia at one medical center in Southern California had "consistently low" levels of alkaline phosphatase (ALP), researchers said, which could ...

Depression relief was the primary driver of disease improvement among patients with fibromyalgia and prominent anxiety and depression symptoms.

When a patient with fibromyalgia is not responding to standard treatments, adding a noninvasive brain therapy might help them feel better. Repetitive transcranial magnetic stimulation (rTMS) of the ...

CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s narrated review of the ...

There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia, according to a study led by researchers at Karolinska ...

Patients suffering from a condition characterized by pain and fatigue could find relief in the form of oral THC treatment, according to newly published research. The study, published in the German ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...